Leafwell
Onur Ç.'s work experience begins in 2004 when they worked in investment banking at ABN AMRO. In 2005, they joined McKinsey & Company as an Associate Partner, where they stayed until 2015. From 2015 to 2017, they worked as an Interim Consultant at Pluc Consulting. In 2017, they joined Fontem Ventures B.V. as the Chief Strategy Officer and Head of Product for blu, a position they held until 2020. Currently, they serve as the Chief Commercial Officer and Board Member at Leafwell.
Onur Ç. has an M. Sc degree in Finance from Erasmus University Rotterdam. Additionally, they have also pursued an MBA from INSEAD. However, the specific start and end years for both educational experiences were not provided.
This person is not in any offices
Leafwell
2 followers
At Leafwell, we firmly believe in the medicinal power of cannabis. This versatile and safe plant holds the potential to effectively treat a myriad of health conditions affecting millions globally, yet its full potential remains untapped. Our diverse team comprises medical doctors, scientists, technologists, cannabis specialists, and patient advocates, all united by a common mission: to unlock the therapeutic potential of cannabis. We aim to achieve this by enhancing accessibility, fostering research, and promoting education about cannabis. We are proud to connect patients to licensed healthcare providers across 34 states in the US. Our process is designed to be swift, simple, and affordable, so our paitents can obtain their medical marijuana cards with ease. These cards are crucial in providing legal and safe access to the therapeutic benefits of medical marijuana. At Leafwell, we are committed to facilitating access and equally dedicated to expanding our collective understanding of cannabis as a medicine through ongoing education and research. Join us as we explore the untapped potential of cannabis and transform the landscape of healthcare.